Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001193125-25-145724
Filing Date
2025-06-24
Accepted
2025-06-24 16:06:11
Documents
11
Effectiveness Date
2025-06-24

Document Format Files

Seq Description Document Type Size
1 S-8 d858624ds8.htm S-8 56267
2 EX-4.1 d858624dex41.htm EX-4.1 77341
3 EX-5.1 d858624dex51.htm EX-5.1 14298
4 EX-23.1 d858624dex231.htm EX-23.1 1508
5 EX-23.2 d858624dex232.htm EX-23.2 1501
6 EX-99.1 d858624dex991.htm EX-99.1 55455
7 EX-99.2 d858624dex992.htm EX-99.2 55434
8 EX-FILING FEES d858624dexfilingfees.htm EX-FILING FEES 18531
9 GRAPHIC g858624g0621010800540.jpg GRAPHIC 3044
10 GRAPHIC g858624snap1.jpg GRAPHIC 5713
11 GRAPHIC g858624snap2.jpg GRAPHIC 4618
  Complete submission text file 0001193125-25-145724.txt   300242
Mailing Address 107 AVENUE DE LA REPUBLIQUE CHATILLON I0 92320
Business Address 107 AVENUE DE LA REPUBLIQUE CHATILLON I0 92320 33(0)155427878
DBV Technologies S.A. (Filer) CIK: 0001613780 (see all company filings)

EIN.: 000000000 | State of Incorp.: I0 | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-288279 | Film No.: 251069004
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)